( July 18, 2025, 4:05 PM EDT) -- SAN FRANCISCO — A shareholder of Hims & Hers Health Inc. on July 17 filed a stockholder derivative action in a California federal court on behalf of the company, accusing the company’s board of directors and executives of misleading the shareholders about a collaboration with Novo Nordisk Inc. that would allow Hims to sell compounded semaglutide products....